Product Program year 2025 Source: CMS Open Payments

ReDS system

Device Heart failure

Open in the dashboard

General payments

$351,349

98 payments

Research payments

$549,718

8 payments

Through program year 2025, $351,349 in general payments and $549,718 in research payments were reported against ReDS system (Heart failure).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

10 rows
Year Kind Amount Payments
2025 General $69,763 33
2024 General $36,000 1
2023 General $40,954 2
2022 General $59,873 2
2022 Research $55,000 1
2021 Research $15,000 1
2020 General $20,000 2
2020 Research $215,000 2
2019 General $124,759 58
2019 Research $264,718 4

Breakdown

Who paid General payments · program years 2019–2025
  1. Sensible Medical Innovations Ltd $286,914 11 payments
  2. Sensible Medical Innovations Inc $64,434 87 payments
Top recipients General payments · program year 2025
  1. William Abraham Advanced Heart Failure and Transplant Cardiology · Columbus, OH $36,000 52% · 1 payment
  2. Daniel Bensimhon Advanced Heart Failure and Transplant Cardiology · Greensboro, NC $33,000 47% · 1 payment
  3. Wesley Tyree Cardiovascular Disease · Scottsdale, AZ $112 <1% · 1 payment
  4. Ralph Ensley Advanced Heart Failure and Transplant Cardiology · Tulsa, OK $56 <1% · 1 payment
  5. Mark Zucker Advanced Heart Failure and Transplant Cardiology · Morristown, NJ $35 <1% · 1 payment

The top 5 of 33 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Advanced Heart Failure and Transplant Cardiology Internal Medicine $69,235 99% · 12 practitioners
  2. Cardiovascular Disease Internal Medicine $371 <1% · 14 practitioners
  3. Internal Medicine $93 <1% · 4 practitioners
  4. Pulmonary Disease Internal Medicine $35 <1% · 2 practitioners
  5. Interventional Cardiology Internal Medicine $28 <1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. Ohio $36,000 52% · 1 recipient
  2. North Carolina $33,000 47% · 1 recipient
  3. Texas $198 <1% · 10 recipients
  4. New Jersey $148 <1% · 6 recipients
  5. Arizona $137 <1% · 3 recipients

The top 5 of 13 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

98 general · 8 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record